New insight in antiplatelet therapy monitoring in cardiovascular patients: from aspirin to thienopyridine.

Hezard, N; Tessier-Marteau, A; Macchi, L

Hezard, N; Tessier-Marteau, A; Macchi, L.

Affiliation

Hezard N; Laboratoire d'Hématologie, CHU Angers, France.

Cardiovasc Hematol Disord Drug Targets ; 10(3): 224-33, 2010 Sep 01.

Article in En | MEDLINE | ID: mdl-20678066

Subject(s)

Aspirin/therapeutic use; Cardiovascular Diseases/drug therapy; Platelet Aggregation Inhibitors/therapeutic use; Pyridines/therapeutic use; Aspirin/adverse effects; Humans; Platelet Aggregation Inhibitors/adverse effects; Pyridines/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Platelet Aggregation Inhibitors / Cardiovascular Diseases / Aspirin Type of study: Clinical_trials Limits: Humans Language: En Journal: Cardiovasc Hematol Disord Drug Targets Journal subject: ANGIOLOGIA / CARDIOLOGIA / HEMATOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links